Reporting owner · CIK 0001532793

Stetz Gary S.

Visual SEC Form 4 history across 2 companies, 9 transactions and 2 filings.

ICInterim CEOHepion Pharmaceuticals, Inc.
Open-market mix
Latest filingAug 21, 2026, 08:36 PM
Filings2Form 4 records
Buying$00 purchases
Selling$343.9K8 sales
Net value−$343.9KBuys minus sells
Companies22 securities
Most recentAug 19, 2026grant

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
Forward return is not available yet

We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for this insider's their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.

Monthly open-market activity

Reported purchase and sale transaction counts

Buys Sells
1050-5-108May 26Aug 26

Net value flow

Buys minus sells

May 26
−$343.9K
Aug 26
$0

Transaction texture

Ownership and ticket size

Average P/S size$43K
Median P/S size$43.8K
Direct9
Indirect0
Aug 19, 2026grant

Filing-only signals

Deterministic matches in this insider's history

Derivative Transactionfiling-context1Direct Ownershipfiling-context9Large Holdings Increaseholdings1Repeat Sellerpattern6

Latest Form 4 facts

Quick context from source filings

Latest transaction

sale at Canton Strategic Holdings, Inc. on May 26, 2026 valued at $43,375.

Review SEC filing
Latest buy

No open-market insider purchase is available.

Latest sale

sale at Canton Strategic Holdings, Inc. on May 26, 2026 valued at $43,375.

Review SEC filing

Associated companies

Visual map of known reporting history

HEPAHepion Pharmaceuticals, Inc.1 transactions · latest Aug 21, 2026, 08:36 PMCNTNCanton Strategic Holdings, Inc.8 transactions · latest May 27, 2026, 10:35 PM
TickerInsiderRoleTypeSharesValueCodeSignals90d returnFiledTrans date
HEPAStetz Gary S.
IC
grant1.34M$0A
Derivative Transaction Direct Ownership Large Holdings Increase
0.0%08/2108/19
CNTNStetz Gary S.
DIR
sale12.5k-$4.33MS
Direct Ownership Repeat Seller
−27.6%05/2705/26
CNTNStetz Gary S.
DIR
sale12.8k-$4.42MS
Direct Ownership Repeat Seller
−27.6%05/2705/22
CNTNStetz Gary S.
DIR
sale10.0k-$3.40MS
Direct Ownership Repeat Seller
−27.6%05/2705/22
CNTNStetz Gary S.
DIR
sale15.0k-$5.11MS
Direct Ownership Repeat Seller
−27.6%05/2705/22
CNTNStetz Gary S.
DIR
sale15.0k-$5.11MS
Direct Ownership Repeat Seller
−27.6%05/2705/22
CNTNStetz Gary S.
DIR
sale15.0k-$5.09MS
Direct Ownership Repeat Seller
−27.6%05/2705/22
CNTNStetz Gary S.
DIR
sale10.0k-$3.45MS
Direct Ownership
−27.6%05/2705/22
CNTNStetz Gary S.
DIR
sale10.0k-$3.45MS
Direct Ownership
−27.6%05/2705/22

Stetz Gary S. Insider Activity FAQ

SEC Form 4 context

Who is Stetz Gary S.?

Stetz Gary S. is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001532793.

Which companies has Stetz Gary S. reported transactions for?

Hepion Pharmaceuticals, Inc., Canton Strategic Holdings, Inc.

When was Stetz Gary S.'s latest insider buy?

No open-market insider purchase is available for this period.

When was Stetz Gary S.'s latest insider sale?

sale at Canton Strategic Holdings, Inc. on May 26, 2026 valued at $43,375.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.